AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups | tctmd.com
Triple Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. Mar…
The Challenge of AF and PCI: Practical Strategies to Improve Outcomes - ppt download
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet
Complex Coronary Cases - ppt download
Triple Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. Mar…
Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM
TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention | USC Journal
The ORBITA Trial: PCI vs Placebo Procedure for Angina Relief in Stable Angina - REBEL EM - Emergency Medicine Blog
Contemporary Revascularization Dilemmas in Older Adults | Journal of the American Heart Association
Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial | JACC: Cardiovascular Interventions
Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence - European Journal of Internal Medicine
on behalf of the RE-DUAL PCI Steering Committee and Investigators - ppt download
on behalf of the RE-DUAL PCI Steering Committee and Investigators - ppt download
on behalf of the RE-DUAL PCI Steering Committee and Investigators - ppt download
Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel
Ticagrelor with or without aspirin in high-risk patients after PCI
References in Antithrombotic Therapy for Atrial Fibrillation - CHEST
The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status | tctmd.com
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial - The Lancet
Comparison of Dabigatran Plus a P2Y12 Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI - The American Journal of Medicine
Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a “less is more” concept regimen - Journal of Cardiology
